Skip to content
News
Firebrick Consultant to drive Pharmacy Distribution in Singapore

Firebrick Consultant to drive Pharmacy Distribution in Singapore


Firebrick Pharma (ASX:FRE) is pleased to announce that it has executed a consulting agreement (Agreement) with Keith Shortall, a former senior executive of Johnson & Johnson Consumer Health Asia-Pacific (J&J Consumer Health APAC). The primary goal of the Agreement is to establish pharmacy distribution for Nasodine in Singapore. Secondary objectives include evaluating potential distribution to…

Firebrick Launches Nasodine in Singapore via Nasodine-sg.com

Firebrick Launches Nasodine in Singapore via Nasodine-sg.com


Firebrick Pharma Limited (ASX:FRE) is proud to announce that its product, Nasodine® Nasal Spray, is now available for sale in Singapore. Customers will be able to order the product through Firebrick’s new website dedicated to support Singapore sales: www.nasodine-sg.com In Singapore, Nasodine is classified as a topical antiseptic and does not require approval or licensing…